Diagnostic Hybrids, Inc. Announces Release of Super E-Mix(R) ReadyCells(R)

ATHENS, Ohio--(BUSINESS WIRE)--Diagnostic HYBRIDS announces the release of its patented Super E-Mix cell line for enterovirus culture in the frozen ReadyCells® format. The availability of Super E-Mix in this novel format allows even the smallest clinical laboratory to offer the sensitivity and speed of rapid cell culture for diagnosis of enteroviral infection. The ReadyCells are provided as confluent monolayers in shell vials and stored frozen at -70°C for up to six months, allowing laboratories to keep the cells from a single production lot available while minimizing cell waste. Cells are thawed as needed to meet daily specimen volumes and ready to inoculate with clinical specimen in four minutes with Diagnostic HYBRIDS’ specialized ReadyCells heat block.
MORE ON THIS TOPIC